Additional Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Pulmonary Specialists of The Palm Beaches
    Loxahatchee Groves FL. 33470
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Clinical Research of Gastonia (CRG)
    Gastonia NC. 28054
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Elevate Clinical Research
    Houston TX. 77058
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    El Paso Pulmonary Association, PA
    El Paso TX. 79902
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Clinical Research and Associates, Inc.
    Miami FL. 33126
    View Details

  • Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

    Massachusetts General Hospital
    Boston MA. 02114
    View Details

  • Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia

    State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences
    Buffalo NY. 14203
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Kingston ON. K7M 4E7
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Denver CO. 80206
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Dallas TX. 75254
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Vancouver BC. V5Z 1M9
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Bethlehem PA. 18015
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Oklahoma City OK. 73117
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Boston MA. 02114
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Philadelphia PA. 19104
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Burlington VT. 05401
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    New York NY. 10029
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    El Paso TX. 79902
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Greensboro NC. 27403
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Richmond VA. 23298
    View Details